Stay updated on Cabozantinib for Adrenocortical Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib for Adrenocortical Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib for Adrenocortical Carcinoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision: v3.4.1 replaces v3.4.0. This appears to be a minor site maintenance update with no changes to study content or user interactions.
    Difference
    0.1%
    Check dated 2026-02-06T11:32:01.000Z thumbnail image
  2. Check
    2 days ago
    Change Detected
    Summary
    The page shows a minor system revision update from v3.4.0 to v3.4.1; there are no changes to core content, trial details, or user-facing features. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-05T12:43:16.000Z thumbnail image
  3. Check
    9 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    New revision label 'Revision: v3.3.4' appears, replacing the previous 'Revision: v3.3.3'. This is a minor update that does not affect the study details or outcomes.
    Difference
    0.1%
    Check dated 2026-01-15T03:10:02.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The page now includes a dedicated Locations section with the Texas site information and updates the page revision to v3.3.3. The old 'Texas Locations' label and the previous revision v3.3.2 have been removed.
    Difference
    0.2%
    Check dated 2025-12-24T14:46:33.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    Publication sourcing language was updated to explain that PubMed publications are automatically filled and may not pertain to the study. The revision tag changed from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T14:48:21.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    The page removes a site-wide funding/status notice; the study title, objectives, eligibility, and outcome measures remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-18T07:28:46.000Z thumbnail image

Stay in the know with updates to Cabozantinib for Adrenocortical Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib for Adrenocortical Carcinoma Clinical Trial page.